We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Human mini-brains for reconstituting central nervous system disorders
Summary
This review discussed advances in human brain organoids (mini-brains) for modeling central nervous system disorders, highlighting their potential to overcome limitations of animal models and accelerate drug development for neurological diseases.
Neurological disorders in the central nervous system (CNS) are progressive and irreversible diseases leading to devastating impacts on patients' life as they cause cognitive impairment, dementia, and even loss of essential body functions. The development of effective medicines curing CNS disorders is, however, one of the most ambitious challenges due to the extremely complex functions and structures of the human brain. In this regard, there are unmet needs to develop simplified but physiopathologically-relevant brain models. Recent advances in the microfluidic techniques allow multicellular culture forming miniaturized 3D human brains by aligning parts of brain regions with specific cells serving suitable functions. In this review, we overview designs and strategies of microfluidics-based human mini-brains for reconstituting CNS disorders, particularly Alzheimer's disease (AD), Parkinson's disease (PD), traumatic brain injury (TBI), vascular dementia (VD), and environmental risk factor-driven dementia (ERFD). Afterward, the applications of the mini-brains in the area of medical science are introduced in terms of the clarification of pathogenic mechanisms and identification of promising biomarkers. We also present expanded model systems ranging from the CNS to CNS-connecting organ axes to study the entry pathways of pathological risk factors into the brain. Lastly, the advantages and potential challenges of current model systems are addressed with future perspectives.
Sign in to start a discussion.
More Papers Like This
Towards the development and applications of blood-brain barrier in vitro models for neurotoxicity assessment
This review examined the development and applications of in vitro blood-brain barrier models for assessing neurotoxicity of chemicals, drugs, and particles including nanoplastics. The authors argue that human cell-derived BBB models are critical alternatives to animal testing for predicting neurological effects of emerging contaminants.
Neuropathogenesis-on-chips for neurodegenerative diseases
Researchers reviewed how miniaturized lab-on-a-chip devices that mimic brain tissue are being developed to study neurodegenerative diseases like Alzheimer's and Parkinson's, offering more realistic models than traditional animal tests. These microfluidic systems, combined with stem cells, could accelerate the discovery of new diagnostics and treatments for conditions that affect millions of people worldwide.
Towards the development and applications of blood-brain barrier in vitro models for neurotoxicity assessment
Researchers reviewed the current state of in vitro blood-brain barrier models and their utility for evaluating the neurotoxic potential of environmental contaminants including micro- and nanoplastics. The review identifies validation challenges and argues for more human-relevant model systems to close gaps in regulatory neurotoxicity assessment.
Advancing Microplastic and Nanoplastic Toxicity Assessment: Insights from Human Organoid Models
This review examines how human stem cell-derived organoids are being used to study the toxic effects of microplastics and nanoplastics on human tissues. Researchers found that organoid models of the gut, lung, brain, and other organs provide more human-relevant data than traditional animal testing for assessing plastic particle toxicity. The study suggests that organoid technology could significantly advance understanding of how microplastics affect human health at the tissue and organ level.
Organoid-based platforms for investigating microplastic-induced human organ toxicity
This review examines how lab-grown miniature organ models, called organoids, are being used to study the health effects of micro- and nanoplastic exposure on human tissues. Evidence from brain, heart, lung, liver, kidney, and intestinal organoid models shows that plastic particles can cause oxidative stress, inflammation, cell death, and impaired tissue development. The technology offers a more realistic way to study plastic toxicity compared to traditional cell culture or animal experiments.